Can zinc deficiency impair thyroid hormone receptor function, immune tolerance, and T3 signaling?

Clinical evidence

• Thyroid hormone synthesis and conversion: Zinc is a vital cofactor for the iodothyronine deiodinase enzymes, specifically Type 1 (D1) and Type 2 (D2), which catalyze the peripheral conversion of inactive thyroxine ($T_4$) into biologically active triiodothyronine ($T_3$). Nutritional zinc deficiency significantly reduces hepatic deiodinase activity, resulting in lowered circulating $T_3$ levels and a reduced $T_4$-to-$T_3$ ratio. Clinical studies show that correcting this deficiency through targeted zinc supplementation successfully restores $T_3$ levels and normalization of conversion kinetics.
• Autoimmune susceptibility: Observational data consistently associate zinc deficiency with a higher prevalence of autoimmune thyroid diseases, such as Hashimoto's thyroiditis, and elevated thyroid autoantibody titers. However, while correcting a deficiency helps re-establish baseline tolerance mechanisms, clinical trials evaluating zinc supplementation alone show mixed results in reversing established, high-titer autoantibody levels, suggesting that therapeutic immunocorrection often requires a multi-factorial approach.

Mechanistic explanations

• Receptor structural compromise: Thyroid hormone receptors ($\text{TR}\alpha$ and $\text{TR}\beta$) are ligand-dependent transcription factors that require zinc to maintain structural integrity. Their DNA-binding domains contain two canonical $\text{Cys}_4$ zinc-finger motifs, where eight conserved cysteines coordinate two zinc ions. The first finger dictates sequence-specific recognition of thyroid hormone response elements (TREs), while the second stabilizes dimerization and DNA backbone interactions. Without zinc, the domain misfolds into an inactive aporeceptor. DNA-binding assays demonstrate that zinc deficiency causes an approximate 70% reduction in TR DNA-binding activity, effectively mimicking receptor-level thyroid hormone resistance.
• Immune tolerance disruption: Physiological levels of free zinc stabilize the lineage-defining transcription factor $\text{Foxp3}$ within regulatory T-cells (Tregs). Zinc enhances $\text{TGF}-\beta$-induced $\text{Smad2/3}$ signaling to drive $\text{Foxp3}$ expression, inhibits Sirtuin-1-mediated $\text{Foxp3}$ deacetylation (preventing its degradation), and suppresses the $\text{Foxp3}$ repressor $\text{IRF-1}$. Zinc deficiency disrupts these pathways, impairing Treg differentiation and shifting the immune system toward pro-inflammatory $\text{Th1}$ and $\text{Th17}$ phenotypes.

Bottom line

Zinc deficiency impairs systemic thyroid homeostasis and immune tolerance through clear, biochemically defined pathways. It disrupts the peripheral conversion of $T_4$ to $T_3$ via deiodinase inhibition, compromises cellular $T_3$ signaling by destabilizing the essential zinc-finger domains of thyroid hormone receptors, and undermines immune self-tolerance by impairing $\text{Foxp3}^+$ regulatory T-cell stabilization.